![Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep](/i/c/68e2c147-36c2-4b87-95da-2a1f855fe67d.webp)
Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep
Problems at a Catalent Inc. production facility led US regulators to deny a key drug application from Regeneron
2023-06-29 00:29
![J&J’s $8.9 Billion Talc Deal Faces Key Test in Oakland Trial](/i/c/7f0ab4b2-d9e5-9059-6548-d4e9ac3d9fd2.webp)
J&J’s $8.9 Billion Talc Deal Faces Key Test in Oakland Trial
Johnson & Johnson’s first jury trial in nearly two years over allegations that its talc-based baby powder causes
2023-06-01 06:23
![Seven & I Board Seen Prevailing Over ValueAct at Annual Meeting](/i/c/46f984b5-8d2b-0dfe-fe80-eaba10831154.webp)
Seven & I Board Seen Prevailing Over ValueAct at Annual Meeting
Seven & i Holdings Co. will probably have enough votes to install its proposed slate of directors at
2023-05-24 08:25
![Catalent Cuts Annual Forecast More Than Expected, Delays Earnings Report Again](/i/c/1c8e0c74-df63-8d48-9b1d-d11bc23cc28d.webp)
Catalent Cuts Annual Forecast More Than Expected, Delays Earnings Report Again
Catalent Inc. shares rose after the troubled contract drug manufacturer gave investors some reassurance about a slashed fiscal
2023-05-19 22:20
![Philips Says Recalled Devices Unlikely to Harm Patient Health](/i/c/7205513c-0b06-c387-0f92-30062ee18b9c.webp)
Philips Says Recalled Devices Unlikely to Harm Patient Health
Royal Philips NV said new tests on its recalled sleep apnea products showed the vast majority of the
2023-05-16 14:55
![Drug Contractor Catalent Plunges After Annual Guidance Cut, Results Delayed](/i/c/011aa8ae-341f-50e0-4291-95624d6f7cb4.webp)
Drug Contractor Catalent Plunges After Annual Guidance Cut, Results Delayed
Catalent Inc. shares traded at their lowest in three years following cuts to its annual financial outlook that
2023-05-09 02:28